HEALTHTRONICS OSSATRON

Generator, Shock-wave, For Pain Relief

FDA Premarket Approval P990086 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for certain ergonomic and safety design changes and a device performance change, i. E. , providing the option of using 4 hz frequency of the shock wave delivery, as well as labeling changes in the operator manual to provide adequate instructions and information about these changes. The device, as modified, will be marketed under the trade name healthtronics ossatron(r) and is indicated for use for performing extracorporeal shock wave (esw) treatment in patients with chronic proximal plantar fasciitis that have failed to respond to conservative treatment. Chronic proximal plantar fasciitis is defined as pain in the area of insertion of the plantar fascia on the medial calcaneal tuberosity that has persisted for six months or more.

DeviceHEALTHTRONICS OSSATRON
Classification NameGenerator, Shock-wave, For Pain Relief
Generic NameGenerator, Shock-wave, For Pain Relief
ApplicantSANUWAVE, INC.
Date Received2001-01-12
Decision Date2001-03-30
PMAP990086
SupplementS002
Product CodeNBN
Advisory CommitteePhysical Medicine
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address SANUWAVE, INC. 11680 Great Oaks Way suite 350 alpharetta, GA 30022

Supplemental Filings

Supplement NumberDateSupplement Type
P990086Original Filing
S004 2004-02-09 Normal 180 Day Track No User Fee
S003 2001-11-05 Panel Track
S002 2001-01-12 Real-time Process
S001 2000-10-19 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.